Live Breaking News & Updates on Translational Medicine Solutions

Stay updated with breaking news from Translational medicine solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Elsevier Launches New Pharmapendium, Empowering Pharma Companies to Bring Novel Drugs to Market Faster and Increase Success of Regulatory Submissions

Elsevier Launches New Pharmapendium, Empowering Pharma Companies to Bring Novel Drugs to Market Faster and Increase Success of Regulatory Submissions
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

City Of , United Kingdom , Olivier Barberan , Terri Mueller , Eli Lilly , Pierre Fabre , Drug Administration , Boehringer Ingelheim , United Newsfile Corp , Elsevier Foundation , Translational Medicine Solutions At Elsevier , Devices Agency , European Medicines Agency , Medical Devices Agency , Translational Medicine Solutions , Drug Interaction Risk Calculator , Safety Margin , Safety Margin Tool , Event Reporting System , Drug Efficacy Study Implementation , Diversity Advisory Board ,

Elsevier launches PharmaPendium drug research platform

Elsevier, a global leader in information and data analytics, has launched the new PharmaPendium, sharpening the translational view of a platform that combines extensive preclinical and clinical data, including complete Food and Drug Administration (FDA) and European Medicines Agency (EMA) approval packages, with predictive tools to accelerate drug development. ....

Olivier Barberan , Eli Lilly , Pierre Fabre , Drug Administration , European Medicines Agency , Boehringer Ingelheim , Translational Medicine Solutions At Elsevier , Devices Agency , Medical Devices Agency , Translational Medicine Solutions , Drug Interaction Risk Calculator , Safety Margin , Safety Margin Tool , Event Reporting System , Drug Efficacy Study Implementation , Drug Consult ,